Recently Released Market Study: Croatia Pharmaceuticals & Healthcare Report Q1 2013
BMI View: The Croatian pharmaceutical market continues to pose a challenging environment to domestic and international drugmakers. The economy is expected to contract in 2012 with weak growth returning in 2013 on the anticipation of capital inflows from the EU. The implementation of a clawback tax at the start of the year will increase pricing pressures. VAT rises and inflation suggest growth seen in 2012 will not be due to increased drug consumption. We forecast weak growth in pharmaceutical market...
View full press release